Brooklyn ImmunoTherapeutics Inc News - BTX

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Quarterly Report (10-q)

false12-312023Q10000748592P2Y6MP5Y6MP10DP10D00007485922023-01-012023-03-3100007485922023-05-1100007485922023-03...

Additional Proxy Soliciting Materials (definitive) (defa14a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement...

Annual Report to Security Holders (ars)

Additional Proxy Soliciting Materials (definitive) (defa14a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION...

Proxy Statement (definitive) (def 14a)

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 SCHEDULE 14A INFORMATIONProxy Statement Pursuant to...

Current Report Filing (8-k)

false0000748592NASDAQ00007485922023-05-022023-05-02 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

TABLE OF CONTENTSFiled pursuant to Rule 424(b)(3) Registration No. 333-271279PROSPECTUSEterna Therapeutics Inc.2,930,237 Shares of Common...

Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 SCHEDULE 14A INFORMATIONProxy Statement Pursuant to...

Current Report Filing (8-k)

false0000748592NASDAQ00007485922023-04-052023-04-05 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington...

Amended Statement of Ownership (sc 13g/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the...

Initial Statement of Beneficial Ownership (3)

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

TABLE OF CONTENTSFiled Pursuant to Rule 424(b)(3)Registration No. 333-264585PROSPECTUSEterna Therapeutics Inc. 685,714 Shares of Common...

Initial Statement of Beneficial Ownership (3)

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...

Current Report Filing (8-k)

false000074859200007485922023-01-202023-01-20 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Current Report Filing (8-k)

false0000748592MANASDAQ00007485922023-01-092023-01-09 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

KeepOn 1 year ago

Confused. This is now “Eterna Therapeutics Inc.”?

sick nam vet 2 years ago

I'll get back in after it goes back down to 30 cents again,name change won't help this stock,hide under another name,but it still will be a trash company

👍️0

sick nam vet 2 years ago

Reverse Split Monday and name change,will still be a POS stock.

👍️0

CarlCarlMcB 2 years ago

Monkey pox $$$$$$$ immunity

👍️0

CarlCarlMcB 2 years ago

Thank you guys for selling on the news $))))))) weeeeeeee

👍️0

CarlCarlMcB 2 years ago

Merry Christmas $$$$$$ 80.00 to 110.00

👍️0

erik007tc 2 years ago

“The INSPIRE study achieved its primary objective of identifying patient populations that may benefit from IRX-2 in the neoadjuvant setting,” said Matt Angel, Ph.D., Brooklyn’s CEO. “These encouraging results are a testament to the design of the INSPIRE study and provide a clear path forward for testing in patient populations that may benefit from treatment with IRX-2 in combination with checkpoint inhibitors. The potential to offer an effective, well tolerated treatment to patients with advanced head and neck cancer who are ineligible for chemotherapy is particularly exciting.”

👍️0

CarlCarlMcB 2 years ago

Rock on my brother ‘ 100.00 stock $$$$$$$

👍️0

erik007tc 2 years ago

Time to load… .58-.62 accumulation.

👍️0

KeepOn 3 years ago

What happened here? What will it take to give this some life?

👍️0

makinezmoney 3 years ago

$BTX: There goes $13..... now we get ready to roll

Saw this dwelling but its definitely ready to ramp now.

Give us $20 first

GO $BTX

👍️0

makinezmoney 3 years ago

$BTX: Maybe $30..... but I agree........

Stepping in for some here now with 5k shares at $12.50 :)

Good News on new mRNA shares facility yesterday with Factor BioScience.

https://newsfilter.io/articles/brooklyn-immunotherapeutics-to-participate-in-grand-opening-of-cambridge-based-mrna-cleanroom-facili-2bd447341295688ecc5f481731a970ec

Letss goooooooooooooooooooo

GO $BTX

👍️0

Cubanwinner 3 years ago

back to $50 mark this post

👍️0

CarlCarlMcB 3 years ago

Buy out coming

👍️0

Atlanta1 3 years ago

have you done an update on this? $BTX

👍️0

sick nam vet 3 years ago

Looking for 30.plus to sell

👍️0

Klinsmann 3 years ago

About to breakout again...

👍️0

crudeoil24 3 years ago

BTX > "company said it has established a research and development center in Cambridge, Mass., to pursue its mRNA-based gene editing and cellular therapies.

The company said it has co-located with Factor Bioscience Limited and Novellus Therapeutics Limited, from which Brooklyn has acquired an exclusive worldwide license to develop and commercialize certain cell-based therapies to treat cancer and rare blood disorders, including sickle cell disease, based on the patented technology and know-how of Factor and Novellus.

"We believe co-locating with Factor and Novellus will promote our capability to leverage our collaboration and further our objectives in developing a diversified portfolio of new, advanced therapeutics," said Howard J. Federoff, Brooklyn's chief executive and president.

Brooklyn's recently licensed platform from Factor and Novellus includes three novel technologies that the company expects to pursue at its new R&D location.

The first is a highly efficient mRNA cell reprogramming method. The second is a mRNA-based gene editing technology which can be applied to both allogeneic and autologous cells and which eliminates potential for off-target effects. The third is a proprietary tunable nanolipid delivery system that provides efficient non-viral vector-based delivery of mRNA ex vivo and in vivo to skin, brain, eye and lung tissue."

Write to Chris Wack at chris.wack@wsj.com

👍️0

crudeoil24 3 years ago

S-1 shelf placement may be completed today. $20.00+ on the horison.

👍️0

crudeoil24 3 years ago

Under $20.00 is a great entry. Any time a huge PR/news, catalysts will rocket BTX to all time highs!

imho

👍️0

stoxjock 3 years ago

Missed the entry on pullback to $13.00... will wait for better entry by EOM.

👍️0

ClayTrader 3 years ago

* * $BTX Video Chart 05-24-2021 * *

Link to Video - click here to watch the technical chart video

👍️0

crudeoil24 3 years ago

Ran to 80 few weeks ago. > gene editing is the latest medical technology paving the way for solutions to various diseases.

BTX

👍️0

TheFinalCD 3 years ago

BTX News MRNA

👍️0

conix 3 years ago

It is pretty clear that BTX has to provide more information to shareholders for the sellers to stop selling and finding new buyers.

👍️0

crudeoil24 3 years ago

Huge salaries , larger staff. 9.00 coming soon; unless BTX provides breaking fundamental PR news.

👍️0

Discipline15 3 years ago

First day of reversal looking for confirmation to swing

👍️0

crudeoil24 3 years ago

About time for another Brooklyn run to 77.77

77.77 in AH > BOOOOOOOOOM! MONDAY MORNING!!!!!

👍️0

conix 3 years ago

RSI still is pretty high. Screaming buy when/if it hits RSI of 30.

👍️0

starkd748 3 years ago

No volume on that turd no thanks

👍️0

dalopey 3 years ago

Naw. It's shorting do a rinse & repeat. Squeeze 2.0 coming soon.

👍️0

conix 3 years ago

Looks like the crowd is exiting. To stop this bleeding, BTX really needs to come out with very positive corporate developments.

The harder the run, the more pain there is on the way down. But there will be a higher base that will be built somewhere. Just do not know where that base is.

Other biotechs have begun their consolidation already with that higher base.

👍️0

conix 3 years ago

Moved some of my profits here to CUBT.

Better to get in low and get out when it is high than the other way around. Reddit moves are great because they happen so fast. But once it cools off--well talk to anyone who bought GME at $400.

CUBT is in biotech too. And has an exclusive patent from the NIH. At $0.13 right now.

BTX could run again if the Reddit crowd keeps it up, but a $20 move is only a 30% gain. Looking for much more than that now.

👍️0

dalopey 3 years ago

Yeah so this was another REDDIT short squeeze play like GameStop (GME) and AMC. Wish I'd a known!!
https://www.forbes.com/sites/palashghosh/2021/04/30/reddit-strikes-again-why-is-a-stock-you-never-heard-of-skyrocketing-in-value/?sh=2b81882c63d3

👍️0

powerbattles 3 years ago

WOW:)))Awesome move! Congrats...chart...

[/img]

👍️0

ClayTrader 3 years ago

* * $BTX Video Chart 05-03-2021 * *

Link to Video - click here to watch the technical chart video

👍️0

conix 3 years ago

BTX all over StockTwits

https://www.thelion.com/bin/aio_msg.cgi?cmd=search&symbol=btx&x=0&y=0

👍️0

conix 3 years ago

Careful. Got out at the open--not because I do not think this cannot become another GME play, just that at some point ....

Is Brooklyn ImmunoTherapeutics the next GameStop?

May 01, 2021 4:00 PM ETBrooklyn ImmunoTherapeutics, Inc. (BTX)

By: Jonathan M Block, SA News Editor

One of the best performing stocks in April was Brooklyn ImmunoTherapuetics (NYSEMKT:BTX), which only began trading in late March.
Shares have risen more than 1200% in the last month.

Brooklyn was formed through a reverse merger with the trivia apps company NTN Buzztime.

In April, Brooklyn's biggest announcement was its acquisition of an exclusive license for mRNA gene editing and cell therapies technology.

However, given the sudden rise in share price on little news or other catalysts, some are saying that Brooklyn is the target of a short squeeze play.

Users on the Wall Street Bets Reddit channel, the same group behind GameStop's spectacular rise earlier this year, have said for some time they have wanted to target biotech stocks as potential short squeeze plays.

Joshua Rodriguez of CNA Finance noted last month that before it became Brooklyn Immunotherapeutics, NTN Buzztime was heavily shorted and after the merger, the public float was only 1.12M shares.

The company's sole asset, IRX-2, is in phase 2b for squamous cell cancer of the head and neck and results are expected by the end of 1H 2021.

👍️0

Jess070283 3 years ago

Eager shorts getting squeezed to $100+

👍️0

davidsson10 3 years ago

The gift that keeps on giving.....

👍️0

Mac-A-Million 3 years ago

I was alerted 10 days ago it was under $5 but didn't expect it to move. $$$$$$!

👍️0

Monksdream 3 years ago

This is a 10 day bar/volume chart of hourly pricing for BTX. As one can observe there was a slight uptick in pricing 10 days ago. Hardly noticeable. Volume nothing to write home about. Later, as pricing and volume increased, the ticker symbol appeared on the Barchart Top 100 list. I use it as an alert. What happened after that is impressive. It is in situations like this when I increase my position size, because it makes sense to do so.

👍️0

crudeoil24 3 years ago

77.77 in AH > BOOOOOOOOOM! MONDAY MORNING!!!!!

👍️0

conix 3 years ago

Always tough to rebuy at higher prices. But it was worth it this time for me.

👍️0

Fress 3 years ago

Got lucky today bought 6k shares at 45.00 out 75.00 have a few thousand shares riding on the house now. Weeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeee

$BTX

👍️0

Jess070283 3 years ago

Holy $$$$!!!!

👍️0

ClayTrader 3 years ago

* * $BTX Video Chart 04-30-2021 * *

Link to Video - click here to watch the technical chart video

👍️0

dalopey 3 years ago

Back into BEAST MODE again!!

👍️0

ClayTrader 3 years ago

* * $BTX Video Chart 04-29-2021 * *

Link to Video - click here to watch the technical chart video

👍️0

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Brooklyn ImmunoTherapeutics Inc (BTX)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

BTX News

Quarterly Report (10-q)

Additional Proxy Soliciting Materials (definitive) (defa14a)

Annual Report to Security Holders (ars)

Additional Proxy Soliciting Materials (definitive) (defa14a)

Proxy Statement (definitive) (def 14a)

Current Report Filing (8-k)

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)

Current Report Filing (8-k)

Amended Statement of Ownership (sc 13g/a)

Initial Statement of Beneficial Ownership (3)

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Initial Statement of Beneficial Ownership (3)

Current Report Filing (8-k)

Current Report Filing (8-k)

BTX Discussion

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Brooklyn ImmunoTherapeutics Inc (BTX) News

Brooklyn ImmunoTherapeutics Inc (BTX)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

BTX News

Quarterly Report (10-q)

Additional Proxy Soliciting Materials (definitive) (defa14a)

Annual Report to Security Holders (ars)

Additional Proxy Soliciting Materials (definitive) (defa14a)

Proxy Statement (definitive) (def 14a)

Current Report Filing (8-k)

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)

Current Report Filing (8-k)

Amended Statement of Ownership (sc 13g/a)

Initial Statement of Beneficial Ownership (3)

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Initial Statement of Beneficial Ownership (3)

Current Report Filing (8-k)

Current Report Filing (8-k)

BTX Discussion

Your Recent History

Company

Business

Popular

Get The App